| Teva Pharma AG - Pomalidomid-Teva Mepha 4 mg, Hartkapseln | | 69497 | | 04 | | Pomalidomid-Teva Mepha 4 mg | | Hartkapseln | | L04AX06 | | Pomalidomide | | 11.10.2024 | | |
| | Composition | | pomalidomidum 4 mg, isomaltum 100.4 mg, amylum pregelificatum, natrii stearylis fumaras, Kapselhülle: gelatina, aqua purificata, E 133, E 127, E 171, Drucktinte: lacca, ammoniae solutio concentrata, kalii hydroxidum, E 172 (nigrum), pro capsula corresp. natrium 0.07 mg. | | Packungsbestandteile | | Capsules | | | | | | Principe actif | Concentr. |
|---|
| Pomalidomidum | 4 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Nigrum) | | | | Ammoniae Solutio Concentrata | | | | Amylum Pregelificatum | | | | Aqua Purificata | | | | E 127 | | color. | | E 133 | | color. | | E 171 | | color. | | E 172 | | color. | | Gelatina | | Kapselhülle | | Isomaltum | 100.4 mg | | | Kalii Hydroxidum | | | | Lacca | | Drucktinte | | Natrii Stearylis Fumaras | | |
|
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 007 | 14 | DDP | DDP | A | | Non | | 008 | 21 | DDP | DDP | A | | Non |
|
|
